Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan;9(1):29-34.
doi: 10.1007/s11908-007-0019-y.

Regulatory disincentives for developing antibiotics for common indications

Affiliations

Regulatory disincentives for developing antibiotics for common indications

Guy W Amsden. Curr Infect Dis Rep. 2007 Jan.

Abstract

Pediatric and adult community-acquired respiratory tract infections remain some of the most common reasons for visits to primary care practitioners, and the antibiotics used to treat them are historically highly profitable for their manufacturers. Despite these facts and the continued evolving need for new treatments for these infections, virtually no new agents have been developed in the past decade. This review explores some regulatory guidelines that could potentially explain the dearth of development, and it provides some practical answers for resolving them.

PubMed Disclaimer

Similar articles

References

    1. Curr Opin Infect Dis. 2003 Jun;16(3):265-9 - PubMed
    1. N Engl J Med. 1995 Aug 24;333(8):474-80 - PubMed
    1. Clin Infect Dis. 2006 Jul 1;43(1):8-15 - PubMed
    1. Clin Infect Dis. 2005 Jul 1;41(1):118-21 - PubMed
    1. Clin Infect Dis. 2003 Feb 15;36(4):389-95 - PubMed

LinkOut - more resources